Industryweek 5800 Gsk 1

GSK to Increase Stake in Indian Unit by $1 Billion

Dec. 16, 2013
Goal is to enlarge its presence in emerging markets.

MUMBAI -- GlaxoSmithKline (IW 1000/100) said Monday it intends to increase its stake in its Indian pharmaceutical unit by more than a billion dollars, in a bid to enlarge its presence in emerging markets.

The firm announced an open offer to shareholders to buy 20.61 million shares at 3,100 rupees (US$50) each. The purchase would raise its stake in the local subsidiary from 50.7% to 75%, according to the company.

The parent company said it planned to keep the Indian unit listed after raising the stake.

GSK Pharma makes a range of drugs and vaccines used to treat respiratory problems, skin disease, cancer, diabetes and heart ailments.

This year, GlaxoSmithKline has already raised its stake in another listed Indian subsidiary, GSK Consumer Healthcare, to 72.5% from 43.2%.

Analysts say the moves are part of a bid to enlarge alternative markets given the tough conditions in Europe.

Copyright Agence France-Presse, 2013

Popular Sponsored Recommendations

How Digital Twin Technology is Empowering Manufacturers

Sept. 27, 2023
This FAQ delves into why this technology offers business value and considerations toward implementation.

How to Build Zero-Cost On-Site Solar and Storage Projects

Nov. 25, 2023
The Inflation Reduction Act offers tax credits, incentives, and financing that enable no-cost projects. In Enel’s eBook, discover the critical role that incentives play in your...

Navigating Disruption: A Leader’s Guide to Strategy Under Uncertainty

Nov. 1, 2023
AI, sustainability, digital--industrials are facing disruptive forces that are redefining what it takes to win. What got your company where it is today won’t get you where you...

3D Printing a More Efficient Factory Floor

Nov. 16, 2023
Today’s additive manufacturing platforms make it simple to print a wide range of high-performing industrial parts as soon as possible and right where you need them — unlocking...

Voice your opinion!

To join the conversation, and become an exclusive member of IndustryWeek, create an account today!